Invitae Corp. (New York Stock Exchange:NVTA)
About the company
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Gross Margin (in %)
Operating Margin (in %)
Net Margin (in %)
Dividend Yield (in %)
|Name||Ticker||Market capitalization (in USD Million)||Revenues (in USD Million)||Price/Book||Price/Earning||Net margin (in %)|
|Guardant Health, Inc.||GH||7770.15||245.00||10.52||-100.66||-31.53|
|LHC Group, Inc.||LHCG||5555.20||2091.00||3.96||56.53||4.73|
|1Life Healthcare, Inc.||ONEM||4827.06||292.00||10.38||-60.81||-27.31|
|The Ensign Group, Inc.||ENSG||2376.08||2155.00||3.37||19.20||5.76|
|Acadia Healthcare Co., Inc.||ACHC||2250.16||3130.00||0.92||19.98||3.61|
|Addus HomeCare Corp.||ADUS||1264.90||598.00||2.99||61.46||3.33|
|U.S. Physical Therapy, Inc.||USPH||1056.38||478.00||4.33||35.96||6.03|
|Castle Biosciences, Inc.||CSTL||675.07||61.00||8.75||661.83||9.75|
|The Pennant Group, Inc.||PNTG||640.64||352.00||8.38||152.53||1.19|
|Option Care Health, Inc.||OPCH||627.36||2539.00||2.65||-6.41||-3.63|
|Tivity Health, Inc.||TVTY||540.00||1255.00||70.31||-1.09||-38.98|
|Fulgent Genetics, Inc.||FLGT||324.20||35.00||4.32||-1621.00||-1.31|
|American Renal Associates Holdings, Inc.||ARA||205.12||824.00||-2.54||-11.45||-2.19|
|CRH Medical Corp.||CRHM||163.52||117.00||2.15||112.00||1.52|
|Guardion Health Sciences, Inc.||GHSI||35.70||1.00||2.62||-1.56||-824.43|
|Cardiff Oncology, Inc.||CRDF||30.17||0.00||12.31||-1.97||-883.77|
|OncoSec Medical, Inc.||ONCS||25.61||None||2.10||-0.68||None|
|Capital Senior Living Corp.||CSU||20.16||439.00||-0.64||-0.29||-16.00|
|American Shared Hospital Services||AMS||12.66||20.00||0.46||52.75||1.28|
|IMAC Holdings, Inc.||IMAC||10.98||16.00||1.26||-1.63||-42.30|
Latest insider transactions
|Date||Role||Name||Transaction||Quantity||Quantity Owned After|
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds ...
INVITAE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Invitae Corporation - NVTA
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are ...
Object reference not set to an instance of an object. Advanced medical genetics company Invitae Corp. (NVTA:NYSE) and ...
BRIEF-Invitae - On Termination Of Merger Under Specified Circumstances, Co May Be Obligated To Pay A Termination Fee Of $30 Mln
UPON TERMINATION OF MERGER UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE OBLIGATED TO PAY A TERMINATION FEE OF $30.0 MILLION Source text for Eikon: bit.ly/3fNrYKK Further company coverage: Our ...
Invitae Corporation NVTA is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. Recently, the 50 Day ...
Invitae Corp. wants a piece of the prenatal screening pie, and the company just struck two deals to make that happen. Invitae Corp. wants to be a comprehensive provider of genetic information through ...
BOULDER — ArcherDX Inc. CEO Jason Myers said his company would have had a “white-hot” initial public offering, but opted to take a $1.4 billion takeover offer from Invitae Corp. (NYSE: NVTA) because ...